Abstract
JL1 is a novel thymocyte-differentiated antigen strictly confined to stage II immature cortical thymocytes. It is expressed in several types of leukemias and lymphomas. Murine anti-JL1 monoclonal antibody labeled with 131I and 99mTc showed 60-70% of immunoreactivity and 1.4-1.9 x 10(9) L/mol of affinity constant. The incubation of the radiolabeled antibody with Molt-4 cells showed no evidence of modulation or shedding. Localization indices increased from day 3 to day 5 in SCID mice bearing Molt-4 cells.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies, Monoclonal* / immunology
-
Antibodies, Monoclonal* / pharmacokinetics
-
Antigens, Differentiation, T-Lymphocyte / analysis*
-
Antigens, Differentiation, T-Lymphocyte / immunology
-
Hematologic Neoplasms / diagnostic imaging*
-
Iodine Radioisotopes
-
Male
-
Mice
-
Mice, Inbred BALB C
-
Mice, SCID
-
Radioimmunodetection*
-
Technetium
Substances
-
Antibodies, Monoclonal
-
Antigens, Differentiation, T-Lymphocyte
-
Iodine Radioisotopes
-
JL1 antigen
-
Technetium